United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2009_register
executive
2010-09-23
article
Training Program for Regulatory Project Managers; Information Available to Industry
Notices
D09002ee1bdd7d23c
D09002ee1bdd7d2b4
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is announcing the continuation of the Regulatory Project Management Site Tours and Regulatory Interaction Program (the Site Tours Program). The purpose of this document is to invite pharmaceutical companies interested in participating in this program to contact CDER.
74 FR 305
https://www.govinfo.gov/app/details/FR-2009-01-05/E8-31320
E8-31320
fr05ja09-69
4160-01-S
Docket No. FDA-2008-N-0651
https://www.govinfo.gov/app/details/FR-2009-01-05/E8-31320
https://www.govinfo.gov/content/pkg/FR-2009-01-05/html/E8-31320.htm
https://www.govinfo.gov/content/pkg/FR-2009-01-05/pdf/E8-31320.pdf
2 p.
305
306
74 FR 305
Training Program for Regulatory Project Managers; Information Available to Industry; Federal Register Vol. 74, Issue
NOTICE
E8-31320
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2009-03-06
Docket No. FDA-2008-N-0651
4160-01-S
E8-31320
Notice.
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is announcing the continuation of the Regulatory Project Management Site Tours and Regulatory Interaction Program (the Site Tours Program). The purpose of this document is to invite pharmaceutical companies interested in participating in this program to contact CDER.
Pharmaceutical companies may submit proposed agendas to the agency by March 6, 2009.
Beth Duvall-Miller, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 6466, Silver Spring, MD 20993-0002, 301- 796-0700, e-mail: elizabeth.duvallmiller@fda.hhs.gov.
Training Program for Regulatory Project Managers; Information Available to Industry,
elizabeth.duvallmiller@fda.hhs.gov
Federal Register
Vol. 74, no. 2
Office of the Federal Register, National Archives and Records Administration
2009-01-05
continuing
daily
deposited
born digital
198 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2009-01-05
P0b002ee1809a3bcb
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr05ja09
https://www.govinfo.gov/app/details/FR-2009-01-05
https://www.govinfo.gov/content/pkg/FR-2009-01-05/pdf/FR-2009-01-05.pdf
https://www.govinfo.gov/content/pkg/FR-2009-01-05/xml/FR-2009-01-05.xml
fdlp
201
391
DGPO
2010-09-23
2023-05-02
FR-2009-01-05
machine generated
eng
FR
FR-2009-01-05
74
2